Short answer
Hereditary thrombophilia testing looks for inherited tendencies toward venous blood clots. The usual items are Factor V Leiden and prothrombin G20210A, and sometimes protein C, protein S, or antithrombin evaluation is added when the family or clot history suggests it. The key question is not “Is this panel positive?” but “Will the result change prevention, treatment duration, pregnancy planning, or family testing?”
What may be included
| Category | Examples | Key caveat |
|---|---|---|
| Common DNA variants | Factor V Leiden, prothrombin G20210A. | Many carriers never develop clots; context drives risk. |
| Natural anticoagulant genes | PROC, PROS1, SERPINC1. | Some labs also order activity or antigen tests, which are not the same as DNA testing. |
| Acquired clotting disorders | Antiphospholipid syndrome testing may be ordered separately. | Not the same as inherited thrombophilia. |
When testing helps
ASH guidance supports selected situations where testing may change care. That can include a strong family history, unusual clot patterns, pregnancy planning, or a situation where the answer could affect how long anticoagulation is used or whether relatives need targeted testing. It is not a universal screen for every clot or every hormone decision.
That distinction matters because overtesting can create more confusion than clarity.
When results can mislead
A positive result does not automatically mean lifelong blood thinners. A negative result does not remove clot risk from surgery, cancer, estrogen exposure, immobility, smoking, pregnancy, or prior thrombosis. Protein C, protein S, and antithrombin results can also be distorted by acute clot, anticoagulants, pregnancy, liver disease, or other acquired conditions.
In other words, timing and clinical context matter as much as the lab name.
Family screening and pregnancy planning
If a known pathogenic familial variant is found, targeted testing in relatives can be useful because it may change counseling for estrogen exposure, pregnancy, surgery, or travel. But family testing should be tied to a concrete decision, not done because the word “thrombophilia” sounds scary.
Pregnancy planning deserves special care because clot risk, miscarriage history, and anticoagulant choices can all affect the plan.
Questions to ask
- What decision changes if the panel is positive or negative?
- Was the clot provoked or unprovoked, and does that change whether testing helps?
- Are we testing inherited thrombophilia, antiphospholipid syndrome, or both?
- Could anticoagulants, pregnancy, acute thrombosis, or liver disease distort protein C, protein S, or antithrombin results?
- Should relatives get targeted testing for a known family variant?
- Will the result change pregnancy, estrogen, or long-term anticoagulation planning?
FAQ
What does a hereditary thrombophilia panel usually include?
It usually includes Factor V Leiden and prothrombin G20210A, and sometimes protein C, protein S, or antithrombin evaluation depending on the clinical question.
When is thrombophilia testing more likely to help?
ASH guidance says testing may be useful in selected situations where the result could change prevention, treatment duration, pregnancy planning, or family testing.
Does a negative panel rule out clot risk?
No. Surgery, cancer, pregnancy, estrogen exposure, immobility, smoking, and prior clots can still drive risk even when a hereditary panel is negative.
Why can protein C, protein S, or antithrombin results be tricky?
Those results can be affected by acute thrombosis, anticoagulants, pregnancy, liver disease, and other acquired conditions, so timing matters.
Is antiphospholipid syndrome the same as inherited thrombophilia?
No. Antiphospholipid syndrome is an acquired clotting disorder and is usually evaluated separately from inherited DNA-based thrombophilia testing.
Should relatives always be tested if one result is positive?
Not always. Targeted family testing makes the most sense when the result will change management for relatives or clarify a known familial pattern.
Related guides: Factor V Leiden testing, Prothrombin G20210A testing, Protein C, protein S, and antithrombin testing, and antiphospholipid syndrome antibody testing.